Skip Main Navigation
Page Content

Save This Event

Event Saved

The Race to Market: Building an Efficient Data Discovery Engine

JLABS San Diego

Wednesday, December 14, 2016 from 8:30 AM to 12:00 PM (PST)

The Race to Market: Building an Efficient Data...

Registration Information

Registration Type Sales End Price Fee Quantity
General Public 3d 17h 48m $35.00 $2.92
Student/Academic 3d 17h 48m $20.00 $2.09
Volunteer   more info Ended Free $0.00
Media/Press   more info Ended Free $0.00

Share The Race to Market: Building an Efficient Data Discovery Engine

Event Details

Are you confident in the quality of your data? Every day, hundreds of scientists are generating, analyzing and managing data that form the basis to discover and develop new drugs that patients are waiting for. Laboratory data forms the building blocks of the scientific work and its quality is critical to crucial business decisions and long term success. JLABS, the Johnson & Johnson Innovation Centers and Janssen R&D invite you to take an in-depth look into potential quality risks in research and explore measures to improve processes in drug discovery.

From emerging startup to big pharma - your company’s reputation, intellectual property protection and decision making depends on high quality data. Presentations will cover the following topics:

  • A journey to bringing a drug to market
  • Dilemmas in discovery – a workshop
  • Reproducibility in research
  • A quality approach within Janssen R&D



Event Partner:
    


Agenda:

8:30 AM | Registration, Breakfast and Networking
9:00 AM | A roadmap to bringing a drug to market
  - Drug discovery process
- Internal and external stakeholders
- Opportunities and challenges
9:25 AM | Dilemmas in discovery – a workshop
  - - An interactive session focusing on potential data handling dilemmas and their associated risks
10:45 AM | BREAK
11:00 AM | Reproducibility in research
  - Experiment reproducibility
- Retractions in research
- Potential root causes
11:20 AM | Discovery data integrity – a quality approach for Janssen R&D
  - Sponsorship and support
- Training approach
- Risk-based monitoring
- Phase appropriate solutions
11:40 AM | Q&A
12:00 PM | Program Close




Speakers
David Malwitz | Manager, Bioresearch Quality & Compliance Janssen R&D read bio»
Lynn Young | Sr. Research Manager, Alliance Business & Portfolio Management Janssen R&D read bio»
Jennifer Towne | Sr. Scientific Director, Immunology Discovery Janssen R&D read bio»


Fees:
$35 | General Public
$20 | Students/Academic
$45 | At the door


Location:
JLABS
3210 Merryfield Row
San Diego, CA


Speakers' Biographies:

David Malwitz | Manager, Bioresearch Quality & Compliance, Janssen R&D
David is responsible for the planning and execution of external strategy in the non-regulated QA domain of Bioresearch Quality & Compliance. This includes implementing key systems and processes needed to establish a risk-based audit program, operationalizing strategic quality and compliance capabilities, and recruiting the right team and network across global R&D sites to enable a successful portfolio. In addition, David supports the internal quality maintenance program by leading internal and external assessments across multiple therapeutic areas and has supported compliance integration efforts to ensure the successful alignment of acquired assets into the Janssen R&D organization. David began his career as a research scientist at Wyeth Research and Amgen. He has a M.S. in Organic Chemistry from Wright State University and B.S. in Chemistry from Cedarville University.
Connect with David: Connect on LinkedIn



Lynn Young | Sr. Research Manager, Alliance Business & Portfolio Management, Janssen R&D
Lynn enables the “business of science” for Discovery Immunology team at Janssen Research & Development. Her focus areas include driving the end-to-end contracts process, ensuring Heathcare Compliance for contracts, monitoring records management and promoting Discovery Data Integrity (DDI) practices. Lynn is a protein biochemist and began her career in the pharmaceutical industry at Tanabe Research Laboratories USA focusing on integrin targets. From there she moved to the RW Johnson Pharmaceutical Research Institute to support drug discovery in the Virology, Infectious Diseases and later the Immunology departments. In 2010, she transitioned to a strategy and operations team supporting the business needs within Research Immunology. Lynn has a M.S. in Biology from the University of California at Irvine and a B.A. in Biochemistry and Cell Biology from University of California at San Diego.
Connect with Lynn: Connect on LinkedIn



Jennifer Towne | Sr. Scientific Director, Immunology Discovery, Janssen R&D
Dr. Towne completed her doctoral degree in the Department of Molecular Genetics, Biochemistry, and Microbiology at the University of Cincinnati School of Medicine where she studied the role of aquaporins in pulmonary inflammation and edema. She subsequently joined Immunex as a post-doctoral fellow investigating the role of novel IL-1 family members in physiology and pathophysiology. Dr. Towne was hired at Immunex as a full time scientist and worked at Immunex/Amgen for 13 years focusing first on the biology of IL-1 family members, primarily IL-36, IL-17 family members and IL-23 in the skin, lung and gut. She led or was a key contributor to multiple large and small molecule project teams currently in clinical development for psoriasis and inflammatory bowel disease (IBD). For the last several years she was responsible for developing the strategy and leading the IBD discovery team at Amgen. Dr. Towne started at Janssen in November 2014 as Scientific Director, Immunology Discovery, where she was responsible for the IBD discovery efforts on the west coast. Dr. Towne is currently the discovery lead for the IBD disease area stronghold where she is responsible for discovery efforts to develop innovative therapeutics for the treatment, prevention and cure of IBD.
Connect with Jennifer: Connect on LinkedIn



Have questions about The Race to Market: Building an Efficient Data Discovery Engine? Contact JLABS San Diego

Save This Event

Event Saved

When & Where


JLABS
3210 Merryfield Row
San Diego, CA 92121

Wednesday, December 14, 2016 from 8:30 AM to 12:00 PM (PST)


  Add to my calendar

Organizer

JLABS San Diego

JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer
The Race to Market: Building an Efficient Data Discovery Engine
Things to do in San Diego, CA Conference Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.